ID Genomics (IDG) invents dipstick-based rapid test for all genetic variants of SARS-CoV-2 – ET HealthWorld
Seattle :ID Genomics (IDG), a Seattle-based company, has invented a dipstick-based, rapid test for simultaneous identification of a large number of genetic variants of SARS-CoV-2 and has just received a National Institutes of Health (NIH) grant to expedite bringing this test to market. The test will ‘fingerprint’ at once all currently known COVID-19 variants of … Read more